Glomega Inc. is a Life Science company focused on biomarker based molecular diagnostics of diabetes.

Our mission is to develop and commercialize early stage tests for diabetes and its complications and effective personalized management of diabetes with novel diagnostic platforms and lower overall healthcare costs.